FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Phyllis Goodman

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Procedures

Anatomy

Prostate

Concepts & Ideas

Activities & Behaviors

Clinical Trials, Phase III as Topic

Co-author Network

Publications

TOP 3
Marian L Neuhouser; Howard L Parnes; Elizabeth A Platz; William D Figg; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing; Alan Kristal; M Scott Lucia; Catherine M Tangen; Yuzhen Tao; Ian M Thompson; Cathee Till; Michael Pollak
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.
Phyllis J Goodman; Jo Ann Hartline; Eric A Klein; Frank L Meyskens; Lori M Minasian; Catherine M Tangen; Monica Yee; Karen Anderson; Kathryn B Arnold; Elise D Cook; John J Crowley; Amy K Darke; Laurence H Baker
Moving a randomized clinical trial into an observational cohort.
Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Sherfaraz K Patel; Elizabeth A Platz; Juergen K Reichardt; Frank Z Stanczyk; Catherine M Tangen; Ian M Thompson; Cathee Till; Adrie Van Bokhoven; Lisa W Chu; William D Figg; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Phyllis Goodman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marian L Neuhouser; Howard L Parnes; Elizabeth A Platz; William D Figg; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing; Alan Kristal; M Scott Lucia; Catherine M Tangen; Yuzhen Tao; Ian M Thompson; Cathee Till; Michael Pollak
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.
Cancer prevention research (Philadelphia, Pa.) 2013;6(2):91-9.
2013: Phyllis J Goodman; Jo Ann Hartline; Eric A Klein; Frank L Meyskens; Lori M Minasian; Catherine M Tangen; Monica Yee; Karen Anderson; Kathryn B Arnold; Elise D Cook; John J Crowley; Amy K Darke; Laurence H Baker
Moving a randomized clinical trial into an observational cohort.
Clinical trials (London, England) 2013;10(1):131-42.
2012: Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Sherfaraz K Patel; Elizabeth A Platz; Juergen K Reichardt; Frank Z Stanczyk; Catherine M Tangen; Ian M Thompson; Cathee Till; Adrie Van Bokhoven; Lisa W Chu; William D Figg; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(10):1823-32.
2012: Siobhan Sutcliffe; Ian M Thompson; Cathee Till; Jonathan M Zenilman; Angelo M DeMarzo; Charlotte A Gaydos; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Frank J Jenkins; William G Nelson; Elizabeth A Platz
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Cancer causes & control : CCC 2012;23(9):1511-8.
2011: Eric A Klein; Laurence Klotz; Michael M Lieber; Scott M Lippman; M Scott Lucia; Frank L Meyskens; Lori M Minasian; Howard L Parnes; J Kellogg Parsons; Catherine M Tangen; Ian M Thompson; Philip J Walther; Joseph L Chin; John J Crowley; Amy K Darke; Leslie G Ford; J Michael Gaziano; Gary E Goodman; Phyllis J Goodman; Daniel D Karp; Laurence H Baker
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
JAMA : the journal of the American Medical Association 2011;306(14):1549-56.
2011: Li Tang; Catherine M Tangen; Ian M Thompson; Cathee Till; Yue Wu; Song Yao; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing; Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Elizabeth A Platz; Juergen K V Reichardt; Regina M Santella; Frank Z Stanczyk; Christine B Ambrosone
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Carcinogenesis 2011;32(10):1500-6.
2011: Song Yao; Christine B Ambrosone; William D Figg; Phyllis J Goodman; Ann W Hsing; Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Howard L Parnes; Elizabeth A Platz; Douglas K Price; Juergen K V Reichardt; Regina M Santella; Frank Z Stanczyk; Li Tang; Catherine M Tangen; Ian M Thompson; Cathee Till; Ashraful Hoque
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Cancer causes & control : CCC 2011;22(8):1121-31.
2010: Phyllis J Goodman; Catherine M Tangen; Alan R Kristal; Ian M Thompson; M Scott Lucia; Elizabeth A Platz; William D Figg; Ashraful Hoque; Ann W Hsing; Marian L Neuhouser; Howard L Parnes; Juergen K V Reichardt; Regina M Santella; Cathee Till; Scott M Lippman
Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.
Cancer prevention research (Philadelphia, Pa.) 2010;3(12):1523-33.
2009: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Eric A Klein
Chemoprevention of prostate cancer.
The Journal of urology 2009;182(2):499-507; discussion 508.
2008: Mary W Redman; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Charles A Coltman; Ian M Thompson
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.
Cancer prevention research (Philadelphia, Pa.) 2008;1(3):174-81.
2008: M Scott Lucia; Amy K Darke; Phyllis J Goodman; Francisco G La Rosa; Howard L Parnes; Leslie G Ford; Charles A Coltman; Ian M Thompson
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
Cancer prevention research (Philadelphia, Pa.) 2008;1(3):167-73.
2007: M Scott Lucia; Jonathan I Epstein; Phyllis J Goodman; Amy K Darke; Victor E Reuter; Francisco Civantos; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Francisco G La Rosa; Michael W Kattan; E David Crawford; Leslie G Ford; Charles A Coltman; Ian M Thompson
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(18):1375-83.
2007: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3076-81.
2007: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Howard L Parnes; Scott M Lippman; Charles A Coltman
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
The Journal of urology 2007;177(5):1749-52.
2006: Zhihong Gong; Marian L Neuhouser; Phyllis J Goodman; Demetrius Albanes; Chen Chi; Ann W Hsing; Scott M Lippman; Elizabeth A Platz; Michael N Pollak; Ian M Thompson; Alan R Kristal
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(10):1977-83.
2006: Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
Journal of the National Cancer Institute 2006;98(16):1128-33.
2006: Phyllis J Goodman; Ian M Thompson; Catherine M Tangen; John J Crowley; Leslie G Ford; Charles A Coltman
The prostate cancer prevention trial: design, biases and interpretation of study results.
The Journal of urology 2006;175(6):2234-42.
2006: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2006;98(8):529-34.
2006: Alan R Kristal; Chen Chi; Catherine M Tangen; Phyllis J Goodman; Ruth Etzioni; Ian M Thompson
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.
Cancer 2006;106(2):320-8.
2005: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Erectile dysfunction and subsequent cardiovascular disease.
JAMA : the journal of the American Medical Association 2005;294(23):2996-3002.
2005: Eric A Klein; Catherine M Tangen; Phyllis J Goodman; Scott M Lippman; Ian M Thompson
Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7460-6.
2005: Ruth Etzioni; Nadia Howlader; Pamela A Shaw; Donna Pauler Ankerst; David F Penson; Phyllis J Goodman; Ian M Thompson
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
The Journal of urology 2005;174(3):877-81.
2005: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
JAMA : the journal of the American Medical Association 2005;294(1):66-70.
2005: Joseph M Unger; Ian M Thompson; Michael LeBlanc; John J Crowley; Phyllis J Goodman; Leslie G Ford; Charles A Coltman
Estimated impact of the Prostate Cancer Prevention Trial on population mortality.
Cancer 2005;103(7):1375-80.
2005: Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Journal of the National Cancer Institute 2005;97(2):94-102.
2004: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.
The New England journal of medicine 2004;350(22):2239-46.
2004: Phyllis J Goodman; Catherine M Tangen; John J Crowley; Susan M Carlin; Anne Ryan; Charles A Coltman; Leslie G Ford; Ian M Thompson
Implementation of the Prostate Cancer Prevention Trial (PCPT).
Controlled clinical trials 2004;25(2):203-22.
2004: Catherine M Tangen; Phyllis J Goodman; John J Crowley; Ian M Thompson
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.
The Journal of urology 2004;171(2 Pt 2):S64-7.
2003: Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R. Duane Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
The influence of finasteride on the development of prostate cancer.
The New England journal of medicine 2003;349(3):215-24.
2002: Donna K Pauler; Kathryn B Gower; Phyllis J Goodman; John J Crowley; Ian M Thompson
Biomarker-based methods for determining noncompliance in a prevention trial.
Controlled clinical trials 2002;23(6):675-85.
2001: Marian L Neuhouser; Alan R Kristal; Ruth E Patterson; Phyllis J Goodman; Ian M Thompson
Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.
Nutrition and cancer 2001;39(1):12-8.